JVR_2024v14n6

Journal of Vaccine Research 2024, Vol.14, No.6, 297-306 http://medscipublisher.com/index.php/jvr 306 Skibinski D., Jones L., Zhu Y., Xue L., Au B., Lee B., Naim A., Lee A., Kaliaperumal N., Low J., Lee L., Poidinger M., Saudan P., Bachmann M., Ooi E., Hanson B., Novotny‐Diermayr V., Matter A., Fairhurst A., Hibberd M., and Connolly J., 2018, Induction of human T-cell and cytokine responses following vaccination with a novel influenza vaccine, Scientific Reports, 8: 18007. https://doi.org/10.1038/s41598-018-36703-7 Sridhar S., 2016, Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines, Frontiers in Immunology, 7: 195. https://doi.org/10.3389/fimmu.2016.00195 Stacey H., Barjesteh N., Mapletoft J., and Miller M., 2018, “Gnothi Seauton”: leveraging the host response to improve influenza virus vaccine efficacy, Vaccines, 6(2): 23. https://doi.org/10.3390/vaccines6020023 Swain S., Agrewala J., Brown D., Jelley-Gibbs D., Golech S., Huston G., Jones S., Kamperschroer C., Lee W., McKinstry K., Román E., Strutt T., and Weng N., 2006, CD4+ T‐cell memory: generation and multi‐faceted roles for CD4+ T cells in protective immunity to influenza, Immunological Reviews, 211: 8-22. https://doi.org/10.1111/j.0105-2896.2006.00388.x Tan S., Zhang S., Wu B., Zhao Y., Zhang W., Han M., Wu Y., Shi G., Liu Y., Yan J., Wu G., Wang H., Gao G., Zhu F., and Liu W., 2017, Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans, Vaccine, 35(42): 5644-5652. https://doi.org/10.1016/j.vaccine.2017.08.061 Teijaro J., Verhoeven D., Page C., Turner D., and Farber D., 2010, Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms, Journal of Virology, 84(17): 9217-9226. https://doi.org/10.1128/JVI.01069-10 Valkenburg S., Li O., Li A., Bull M., Waldmann T., Perera L., Peiris M., and Poon L., 2018, Protection by universal influenza vaccine is mediated by memory CD4 T cells, Vaccine, 36(29): 4198-4206. https://doi.org/10.1016/j.vaccine.2018.06.007 Zost S., Wu N., Hensley S., and Wilson I., 2019, Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens, The Journal of Infectious Diseases, 219(Supplement 1): S38-S45. https://doi.org/10.1093/infdis/jiy696 Zhou J.R., 2024, Targeted therapy for specific genetic variations in cancer, International Journal of Clinical Case Reports, 14(2): 79-86. https://doi.org/10.5376/ijccr.2024.14.0010

RkJQdWJsaXNoZXIy MjQ4ODYzNQ==